This site uses cookies, tags, and tracking settings to store information to help give you the very best browsing experience. Dismiss this warning

Effect of Bovine Colostrum Supplementation on Respiratory Tract Mucosal Defenses in Swimmers

Click name to view affiliation

Christine Crooks
Search for other papers by Christine Crooks in
Current site
Google Scholar
PubMed
Close
,
Martin L. Cross
Search for other papers by Martin L. Cross in
Current site
Google Scholar
PubMed
Close
,
Clare Wall
Search for other papers by Clare Wall in
Current site
Google Scholar
PubMed
Close
, and
Ajmol Ali
Search for other papers by Ajmol Ali in
Current site
Google Scholar
PubMed
Close
Restricted access

Purpose:

This study investigated the effect of bovine colostrum (BC) on mucosal defense in the respiratory tracts of athletes and a nonexercising control group.

Methods:

An athlete cohort (ATH) of 25 (12 male, 13 female) elite swimmers (age 14–23 yr) and a control cohort (CON) of 28 (9M, 19F) students (age 18–27 yr) were randomly allocated in a double-blind manner to receive either 25 g BC (low-protein colostrum powder) or isocaloric placebo (PL) per day for 10 wk. Postprandial saliva samples were analyzed for immunoglobulins (A, G, and M) and osmolality at baseline, after 4 and 10 wk, and 2 wk postsupplementation. Blood samples were analyzed for immunoglobulins and C-reactive protein at baseline, after 5 and 10 wk, and 2 wk postsupplementation. Dietary intake was assessed by self-recorded dietary records. Upper respiratory tract symptoms (URS) and exercise were also self-recorded daily.

Results:

There was no significant time-related effect of the BC supplement on either saliva or plasma immunoglobulin levels for either cohort. After 4 wk supplementation fewer ATH/BC (25%) than ATH/PL participants (61%) reported URS incidents (p = .062). No significant difference occurred in URS reports in the control group.

Conclusion:

There was no measurable effect on immunoglobulin levels of consuming BC, which is in contrast to effects that have been reported previously in marathon runners, indicating that the effect of BC supplementation is not universal in all groups of athletes. Fewer athletes reported URS (although cause unknown) when consuming BC, which may be advantageous for training.

Crooks is with the Dept. of Virology and Immunology, Auckland Hospital, Auckland, New Zealand. Cross is with Landcare Research, Lincoln, New Zealand. Wall is with the Faculty of Medicine and Health Sciences, Auckland University, Auckland, New Zealand. Ali is with the Institute of Food Nutrition and Human Health, Massey University, Auckland, New Zealand.

  • Collapse
  • Expand
All Time Past Year Past 30 Days
Abstract Views 2642 277 16
Full Text Views 63 20 0
PDF Downloads 80 5 0